High numbers of CD3 + and CD8 + tumour-infiltrating lymphocytes have been observed to predict favourable outcome in muscle-invasive urothelial carcinoma, whereas in low grade non-muscle-invasive carcinoma CD3 + and CD8 + lymphocytes were predictive of bladder cancer recurrence [15–19]. The gene discussed is CD8A; the disease is urinary bladder cancer.